Xceleron (Chapter 11)

Xceleron (Chapter 11)

Xceleron (Chapter 11)

14C AMS analytical tech & clinical design - R&D efficiency - translational science, target turnover, preclinical, Phase 0, enriched Phase I & Phase II/III
Founded
1997
Raised
$10M
Follow us
Alexa global traffic share
Twitter followers
06 Feb 2012
$2,400,000
Venture capital
20 Jan 2010
Undisclosed funding
05 Dec 2006
$3,951,996
Venture capital (Series B)
25 May 2005
$3,653,122
Venture capital